Adial Pharmaceuticals Inc News - ADIL | ADVFN

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Adial Pharmaceuticals Inc (ADIL)
Adial Pharmaceuticals Inc (ADIL) News

Adial Pharmaceuticals Inc (ADIL)

1.18

-0.13

(-9.92%)

At close: July 24 4:00PM

Delayed by 15 minutes

1.18

0.00

( 0.00% )

After Hours: 4:02PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings

CHARLOTTESVILLE, Va., July 11, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL;...

Form 8-K - Current report

Securities Registration Statement (s-1)

As filed with the Securities and Exchange Commission on June 22, 2023 Registration No. 333- ...

Current Report Filing (8-k)

0001513525 false 0001513525 2023-06-09 2023-06-09 0001513525...

Small Company Offering and Sale of Securities Without Registration (d)

UNITED STATES SECURITIESAND EXCHANGE COMMISSIONWashington, D.C.FORM DOMB APPROVALOMB Number: 3235-0076Estimated Average burden hours per...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9th

CHARLOTTESVILLE, Va., June 01, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Current Report Filing (8-k)

0001513525 false 0001513525 2023-05-12 2023-05-12 0001513525...

FROZENFLAME

FROZENFLAME 6 hours ago

Looks like green very soon !

FROZENFLAME

FROZENFLAME 7 hours ago

glenn1919

glenn1919 1 day ago

ADIL............................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783

tw0122

tw0122 1 day ago

Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Source: GlobeNewswire Inc.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the progression to the second cohort in the pharmacokinetics study of AD04, the Company’s lead investigational genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients (defined as < 10 drinks/drinking day), following the successful completion of the first cohort. Topline results from both cohorts are expected to be announced during the fourth quarter of 2024.
Cary Claiborne, President and Chief Executive Officer of Adial commented, “We are pleased with the progress of our pharmacokinetics study of AD04. The successful completion of the first cohort allows us to advance to the second cohort as planned, staying on track with our projected timeline. The results from both cohorts will offer invaluable insights that are critical for the design of our upcoming Phase 3 Clinical Trial. We anticipate engaging with the FDA following receipt of the topline data from this study and seek their feedback on the overall design of our Phase 3 program.”

The pharmacokinetics study was initiated in June 2024 and is expected to be completed during the fourth quarter of 2024. The single-center open-label relative bioavailability and dose proportionality study will enroll up to 30 healthy adult volunteers and compare the pharmacokinetic profile of AD04 when administered as an oral dose of 0.33 mg with or without food against a reference standard product. This study will provide valuable information on the pharmacokinetic properties of AD04.

Monksdream

Monksdream 4 days ago

Monksdream

Monksdream 3 weeks ago

glenn1919

glenn1919 2 months ago

ADIL....................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 3 months ago

Awl416

Awl416 3 months ago

44Skell

44Skell 3 months ago

Where to now ADIL?

Klinsmann

Klinsmann 3 months ago

Sorry to say, I was deadly wrong on this one... But I´m holding and adding.

Klinsmann

Klinsmann 3 months ago

Holding up very well. And flagging for the next uptick. Jep, it‘s supposed to happen…

44Skell

44Skell 3 months ago

Isn’t this stock suppose to be ticking up

Invest-in-America

Invest-in-America 3 months ago

ADIL: Boy, am I eatin' 'CROW' on this one, or what!!! (Likely Close today at $5.00, just to humiliate me even more!!!)

"Heck, I trash a stock, & then it soars to the MOON!!! I HATE when this happens!!! NO RESPECT, at all!!!"

glenn1919

glenn1919 3 months ago

ADIL...............................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783

Invest-in-America

Invest-in-America 3 months ago

ADIL: This is what one gets behind 'investing' in a mere Ultra-Pre-Human-Trials, Petri Dish, Test Tude, Theoretical Journal Paper, and otherwise, 'THE-GREAT-ALCOHOL-ADDICTION-MAYBE-COULD-BE-MIGHT-BE-YEARS-FROM-NOW-CURE-OF-THE-WEEK', fluffy, Wall Street 'news' routine.

TheFinalCD

TheFinalCD 3 months ago

tHANKS adiL 1.82

Klinsmann

Klinsmann 3 months ago

Congrats- chart looks primed for more…

TheFinalCD

TheFinalCD 3 months ago

filled 1.97 on that dip

TheFinalCD

TheFinalCD 3 months ago

$ADIL 2.54 LET MORE GO, WHAT A GREAT STOCK TO TRADE

https://finviz.com/quote.ashx?t=ADIL&ty=c&ta=1&p=d

$adil lots of trade oppshttps://t.co/0eN6zQg6CR— THE FINAL COUNTDOWN (@READY_2_PROFIT) April 10, 2024

TheFinalCD

TheFinalCD 3 months ago

TheFinalCD

TheFinalCD 3 months ago

nhod https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174209695

Klinsmann

Klinsmann 3 months ago

Overdue- go time again!

Awl416

Awl416 3 months ago

Klinsmann

Klinsmann 4 months ago

Added more shares - rumors about a big pharma deal hopefully get published soon…

Monksdream

Monksdream 4 months ago

ADIL 10Q due 3/18

maent

maent 5 months ago

I'm totally out. It was a nice bounce. We will see if it drops back into a buy zone. GL all.

Bill_ENG

Bill_ENG 5 months ago

Except for the failed Phase III and then the company not doing anything except for a reverse split in two years.

They need to run more trials it will take 3 to 4 years to prove effectiveness and a higher probability it will fail those trials.

Having a patent on something that doesn't work is not worth much.

Jmho

glenn1919

glenn1919 5 months ago

ADIL................................................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783

Lottoplay

Lottoplay 5 months ago

“AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity” my projected selling price just went higher! I didn’t know it treated gambling and obesity in addition to alcoholism and opioid addiction! BOOM!!!

Lottoplay

Lottoplay 5 months ago

BOOM! Posted yesterday! “ADIL this company has the potential to be worth #BILLIONS and at the same time help alcoholics and opioid addicts! Making money and helping humanity, who doesn’t want to be a part of that!”

maent

maent 5 months ago

I'm now looking for a nice bounce over $5

BurgerKing82

BurgerKing82 5 months ago

This one looks good

Lottoplay

Lottoplay 5 months ago

$ADIL this company has the potential to be worth #BILLIONS and at the same time help alcoholics and opioid addicts! Making money and helping humanity, who doesn’t want to be a part of that! 🚀

Awl416

Awl416 5 months ago

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

maent

maent 5 months ago

I'm looking for a nice bounce back over $1

Monksdream

Monksdream 5 months ago

ADIL new 52 week low

maent

maent 5 months ago

My stop loss hit at 1.04

Monksdream

Monksdream 5 months ago

ADIL new 52 week low

Monksdream

Monksdream 5 months ago

ADIL new 52 week low

maent

maent 5 months ago

Looks like a nice entry point here.

eb0783

eb0783 5 months ago

Cat got your tongue?

Monksdream

Monksdream 5 months ago

ADIL new 52 week low

Monksdream

Monksdream 6 months ago

ADIL new 52=week low

Monksdream

Monksdream 6 months ago

ADIL new 52 week low

🌈 1 🍆 1 👎️ 1 🤡 1 🩳 1

Monksdream

Monksdream 6 months ago

ADIL new 52 week high

Monksdream

Monksdream 6 months ago

ADIL new 52 week low

Muhbruh

Muhbruh 7 months ago

$ADIL another small bio getting attention now pic.twitter.com/oCNyRr81Tj— STOCKS Gambino (@StocksGambino) December 29, 2023

Zorro

Zorro 7 months ago

Volume picking up but also dropping in price. Looks like there is historic support in the 1.80 area.

MrBuckets

MrBuckets 8 months ago

Holding on for the fun next week

Adial Pharmaceuticals

Delayed Upgrade Clock